Abstract:Background Therapeutic strategies for preventing paradoxical reperfusion injury after myocardial ischemia are limited. We tested whether central nervous system actions of leptin induce important protective effects on cardiac function and metabolism after myocardial ischemia/reperfusion (I/R) injury, the role of cardiac sympathetic innervation in mediating these effects, and whether there are major sex differences in the cardioprotective effects of chronic central nervous system leptin infusion. Methods and Results Myocardial I/R was induced by temporary ligation of the left descending coronary artery in male and female Wistar rats instrumented with intracerebroventricular cannula in the lateral ventricle. Vehicle or leptin (0.62 μg/h) infusion was started immediately after reperfusion and continued for 28 days using osmotic minipumps connected to the intracerebroventricular cannula. Cardiac function was assessed by echocardiography, ventricular pressures, and exercise performance. Intracerebroventricular leptin treatment markedly attenuated cardiac dysfunction post‐I/R as evidenced by improved ejection fraction (56.7±1.9 versus 22.6%±1.1%), maximal rate of left ventricle rise (11 680±2122 versus 5022±441 mm Hg) and exercise performance (−4.2±7.9 versus −68.2±3.8 Δ%) compared with vehicle‐treated rats. Intracerebroventricular leptin infusion reduced infarct size in females, but not males, when compared with ad‐lib fed or pair‐fed saline‐treated rats. Intracerebroventricular leptin treatment also increased cardiac NAD + /NADH content (≈10‐fold) and improved mitochondrial function when compared with vehicle treatment. Cervical ganglia denervation did not attenuate the cardiac protective effects of leptin after I/R injury. Conclusions These data indicate that leptin, via its central nervous system actions, markedly improves overall heart function and mitochondrial metabolism after I/R injury regardless of sex, effects that are largely independent of cardiac sympathetic innervation. Nonstandard Abbreviations and Acronyms β‐OHB beta‐hydroxybutyrate AMPK adenosine monophosphate‐activated protein kinase CGx cervical ganglia denervation H 2 O 2 hydrogen peroxide I/R ischemia/reperfusion OXPHOS oxidative phosphorylation ROS reactive oxygen species Clinical Perspective What Is New? Our study reveals a potent cardioprotective effects of leptin, mediated via the central nervous system, that protect the heart after ischemia/reperfusion injury. Central nervous system leptin infusion improves cardiac function in male and female rats after ischemia/reperfusion injury. The cardioprotective effect of central nervous system leptin administration is not mediated by cardiac sympathetic nerves. What Are the Clinical Implications? Understanding the mechanisms by which leptin acts on the central nervous system to regulate cardiac metabolism and function may lead to new, more effective therapeutic strategies for myocardial ischemia and heart failure. Cardiovascular disease remains the leading cause of mortality and is a major health care burden in the United States and worldwide. 1 Approximately 18.2 million Americans suffer from coronary artery disease and ≈20% of patients who experience an acute myocardial infarction (MI) develop heart failure (HF) within 5 years. 2 Reperfusion strategies are currently the primary therapies for acute MI; however, reperfusion of ischemic areas may paradoxically exacerbate MI‐associated myocardial injury, accounting for up to 50% of the final infarct size and increasing the probability of HF development. 3 Although improvements have been made with timely reperfusion strategies and advances in percutaneous coronary intervention technology, effective therapies to protect the heart against ischemia/reperfusion (I/R) injury are still limited. Our recent studies suggest that activation of brain leptin rece -Abstract Truncated-

Hypomethylated leptin receptor reduces cerebral ischaemia-reperfusion injury by activating the JAK2/STAT3 signalling pathway

Exogenous leptin alleviates glutamate-excitotoxic damage caused by cerebral ischemia–reperfusion in mice by affecting the expression of glutamate transporters

UP-REGULATION OF ENDOGENOUS LEPTIN IMPROVES HUMAN MESENCHYMAL STEM CELL SURVIVAL ABILITY IN VITRO AND THIS CELLS PROTECT FATAL CARDIAL MYOCYTES FROM APOPTOSIS

Increased Leptin by Hypoxic-Preconditioning Promotes Autophagy of Mesenchymal Stem Cells and Protects Them from Apoptosis

Leptin Promotes Angiogenesis via Pericyte STAT3 Pathway upon Intracerebral Hemorrhage

Leptin protects brain from ischemia/reperfusion‐induced infarction by stabilizing the blood–brain barrier to block brain infiltration by the blood‐borne neutrophils

Leptin Protects Against 6-Hydroxydopamine-induced Dopaminergic Cell Death Via Mitogen-Activated Protein Kinase Signaling

Inhibition of the JAK2/STAT3 Pathway and Cell Cycle Re-Entry Contribute to the Protective Effect of Remote Ischemic Pre-Conditioning of Rat Hindlimbs on Cerebral Ischemia/reperfusion Injury.

Leptin Neuroprotection in the CNS: Mechanisms and Therapeutic Potentials

Chronic central nervous system leptin administration attenuates kidney dysfunction and injury in a model of ischemia/reperfusion-induced acute kidney injury

Chronic Central Nervous System Leptin Infusion Improves Cardiac Function and Metabolism after Ischemia/Reperfusion Injury

Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1 ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation

Esculentoside H reduces the PANoptosis and protects the blood-brain barrier after cerebral ischemia/reperfusion through the TLE1/PI3K/AKT signaling pathway

The AGEs/RAGE Signaling Pathway Regulates NLRP3-Mediated Neuronal Pyroptosis After MCAO Injury in Lepr-/- Obese Rats

Leptin Promotes the Proliferation and Neuronal Differentiation of Neural Stem Cells through the Cooperative Action of MAPK/ERK1/2, JAK2/STAT3 and PI3K/AKT Signaling Pathways

Leptin Signaling is Required for Augmented Therapeutic Properties of Mesenchymal Stem Cells Conferred by Hypoxia Preconditioning

Anti-IL-23 exerted protective effects on cerebral ischemia–reperfusion injury through JAK2/STAT3 signaling pathway

Levosimendan Ameliorates Hypoxia-Induced Brain Injury in Rats by Modulating PTEN/Akt Signaling Pathway-Mediated Ferroptosis

Histone methyltransferase enzyme enhancer of zeste homolog 2 counteracts ischemic brain injury via H3K27me3‐mediated regulation of PI3K/AKT/mTOR signaling pathway

Central Nervous System Actions of Leptin Improve Cardiac Function After Ischemia–Reperfusion: Roles of Sympathetic Innervation and Sex Differences

Endothelin Receptor Down-Regulation Mediated Ligand Regulation Mechanisms Protect Against Cellular Hypoxia Injury in Rat Vascular Endothelial Cells